Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET PRE-OPEN: S&N CEO Departs; Candy Eyes Capital & Counties

Mon, 21st Oct 2019 07:42

(Alliance News) - Stock prices in London are set for a higher open on Monday with the UK government's attempt to get its Brexit deal approved by Parliament expected to dominate the day.

In early UK company news, takeaway firm Just Eat reported sharp growth in third quarter revenue, AstraZeneca said the US Food & Drug Administration has approved Farxiga and Smith & Nephew has appointed a new chief executive.

A consortium led by luxury property developer Nicholas Candy confirmed it is in the early stages of considering making a cash takeover offer for FTSE 250-listed Capital & County Properties. Capital & Counties has been in the process of demerging its Covent Garden and Earls Court property portfolios in London.

IG futures indicate the FTSE 100 index is to open 12.13 points higher at 7,162.70. The blue-chip index closed down 31.75 points, or 0.4% at 7,150.57 on Friday.

CMC Market's David Madden commented: "Towards the end of last week the mood in the markets was lifted by the news that a Brext deal was struck. The announcement boosted European equity markets in addition to driving sterling higher. Friday was a quiet day in terms of news flow and volatility was low as traders awaited the sitting of Parliament on Saturday."

At the special Saturday sitting, members of Parliament voted by 322 to 306 in favour an amendment withholding approval of his Brexit deal until legislation to implement it is in place.

This means Boris Johnson is set for a showdown with Commons Speaker John Bercow on Monday as the prime minister pushes for a knife-edge Commons vote on his Brexit deal.

Bercow, who Tory Brexiteers have accused of being pro-Remain, will rule on whether the government can bring a so-called "meaningful vote" on its plans.

If the Speaker blocks the move, focus will switch to the government bringing its Withdrawal Agreement Bill before MPs on Monday, with a vote on its second reading on Tuesday.

Ministers insist they "have the numbers" to push the agreement through, but the parliamentary situation appears to be on a tightrope.

"Even if Bercow doesn't allow the meaningful vote, MPs will have an opportunity to vote on the principal of the deal brokered by Boris on Tuesday. Sterling lost ground overnight on the back of the weekend's events," Madden noted.

The pound was quoted at USD1.2924 early on Monday, higher against USD1.2885 at the close Friday.

In UK economic news, consumer confidence decreased in the third quarter, returning to a level last seen in the final quarter of 2018, according to the latest Deloitte Consumer Tracker survey already released.

UK consumer confidence fell by one percentage point to 9% in the third quarter of 2019. The analysis, based on the response of more than 3,000 consumers in the UK between September 27 and 30, revealed sentiment on job security was three points lower year-on-year at 8%.

At the same time, confidence around job opportunities and career progression also fell by five points to 6% over the same period. According to Deloitte's latest survey, businesses are intensifying cost control, with 70% of employers expecting to reduce hiring in the next 12 months.

In early UK company news, Smith & Nephew said Namal Nawana has agreed to step down as chief executive officer, by mutual agreement, at the end of October. Non-Executive Director Roland Diggelmann has been named as his replacement.

Former Roche Holding AG CEO Diggelmann will take over the job on November 1. He has been on Smith & Nephew's board since early 2018.

Smith & Nephew said Nawana is leaving to pursue other opportunities outside the UK.

Takeaway firm Just Eat said it is confident in its current performance and has confirmed its full-year guidance.

Just Eat reported third-quarter group revenue of GBP247.5 million, a 25% jump year on year. In the year to date, which encompasses the nine months to September 30, Just Eat saw revenue grow 28% to GBP717.8 million.

The company said its group orders were up 16% in the quarter to 62 million with UK orders increasing by 8% to 33 million.

Just Eat reaffirmed its 2019 revenue guidance, expecting to report revenue between GBP1.0 billion and GBP1.1 billion for the full year. Underlying earnings before interest, tax, depreciation and amortization is guided to be between GBP185 million and GBP205 million.

Pharma giant AstraZeneca said the US FDA has approved its Farxiga treatment, used to reduce the risk of hospitalisation for heart failure in adults with type-2 diabetes.

Astra's Executive Vice President of its BioPharmaceuticals unit, Ruud Dobber, said Farxiga is the first sodium-glucose cotransporter 2 inhibitor to be approved in the US.

"This is promising news for the 30 million people living with type-2 diabetes in the US, as heart failure is one of the earliest cardiovascular complications for them, before heart attack or stroke. Farxiga now offers the opportunity for physicians to act sooner and reduce the risk of hospitalisation for heart failure," said Dobber.

Farxiga was approved in the EU in August and is currently under regulatory review in China, with a decision anticipated in the first half of 2020.

Midcap software firm Micro Focus International noted the announcement from Open Text Corp, which said it is not considering a potential acquisition of Micro Focus.

Lending platform Funding Circle said it is "confident" it is on the "right course of action" despite the "uncertain economic environment".

At the end third quarter, ended September 30, Funding Circle's loans under management stood at GBP3.7 billion, up 31% on the year before.

Year to date originations are up 9% year on year at GBP1.8 billion.

The Japanese Nikkei 225 closed up 0.3% Monday. In China, the Shanghai Composite is down 0.4%, while the Hang Seng index in Hong Kong is flat.

In the US on Friday, Wall Street ended in the red, with the Dow Jones Industrial Average closing down 1.0%, the S&P 500 0.4% lower, and the Nasdaq Composite 0.8% lower.

The economic events calendar on Monday has Bank of England policymaker Andy Haldane will speak at a joint BoE, Federal Reserve Board and European Central Bank conference in Frankfurt at 1600 BST.

By Paul McGowan; paulmcgowan@alliancenews.com

Copyright 2019 Alliance News Limited. All Rights Reserved.

More News
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.